900175-03-3

Basic information

• Product Name: 5-Ethyl-2-fluorophenylboronic acid
• Synonyms: 5-Ethyl-2-fluorophenylboronic acid
• CAS NO: 900175-03-3
• Molecular Formula: C₈H₁₀BFO₂
• Molecular Weight: 167.9732032
• Mol File: 900175-03-3.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Storage Temp.: Refrigerated.
• Solubility: DMSO (Slightly), Methanol (Slightly)
• CAS DataBase Reference: 5-Ethyl-2-fluorophenylboronic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Ethyl-2-fluorophenylboronic acid(900175-03-3)
• EPA Substance Registry System: 5-Ethyl-2-fluorophenylboronic acid(900175-03-3)

Safety Data

• Hazardous Substances Data: 900175-03-3(Hazardous Substances Data)

Usage

General Description

5-Ethyl-2-fluorophenylboronic acid is a chemical compound with the molecular formula C8H10BFO2. It is commonly used as a building block in the synthesis of various pharmaceuticals and agrochemicals. 5-Ethyl-2-fluorophenylboronic acid is a boronic acid derivative, which makes it a useful reagent in Suzuki-Miyaura cross-coupling reactions. It is also known for its ability to form stable complexes with a variety of metal ions, which has led to its use in the development of various catalysts and materials. Additionally, 5-Ethyl-2-fluorophenylboronic acid has potential applications in the field of organic electronics and materials science due to its unique electronic properties.

Upstream product

• 891843-33-7 2-bromo-4-ethyl-1-fluorobenzene 

Downstream Products

• 900175-05-5 2-(1-di-tert-butoxycarbonylaminoisoquinolin-6-ylamino)-2-(5-ethyl-2-fluoro-phenyl)acetic acid 
• 891843-05-3 5-ethyl-2-fluoro-phenol 
• 1586045-49-9 2-(5-ethyl-2-fluorophenyl)thiazole-4-carboxylic acid 
• 1586041-44-2 N-(5-((2S,5R,6S)-5-amino-6-fluorooxepan-2-yl)-1-methyl-1H-pyrazol-4-yl)-2-(5-ethyl-2-fluorophenyl)thiazole-4-carboxamide 

Relevant articles and documents

SPIRO DERIVATIVES AS VOLTAGE - GATED SODIUM CHANNEL MODULATORS

The invention relates to spiro derivatives, to the use of said derivatives in treating diseases and conditions mediated by modulation of voltage-gated sodium channels, to compositions containing said derivatives and processes for their preparation.

PHENYLGLYCINAMIDE DERIVATIVES USEFUL AS ANTICOAGULANTS

The present invention relates generally to phenylglycinamide derivatives that inhibit serine proteases. In particular it is directed to novel phenylglycinamide derivatives, and analogues thereof, which are useful as selective inhibitors of serine protease enzymes of the coagulation cascade; for example thrombin, factor VIIa, factor Xa, factor XIa, factor IXa, and/or plasma kallikrein. In particular, it relates to compounds that are factor VIIa inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same.